Wimolnut Manheng
United States Food and Drug Administration
ORCID: 0000-0003-3909-086XAlso affiliated with Center for Drug Evaluation and Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer”.
Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H. Fiero, Ankit Shah +20 more
Kristine L. Witt, Helen Cunny, Dori R. Germolec, Daven N. Jackson‐Humbles, David E. Malarkey +12 more
Dori R. Germolec, Victor J. Johnson, Travis V. Gulledge, Wimolnut Manheng, Kimber L. White +5 more
Paul Rogers, Angel Paredes, Wimolnut Manheng, Beverly Lyn‐Cook, Tariq Fahmi +1 more
Dow-Chung Chi, Sundeep Agrawal, Hee‐Koung Joeng, Sarah Kim-McOlash, Wimolnut Manheng +17 more